ITCI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 2.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Intra-Cellular Therapies Insider Trading History Chart

Intra-Cellular Therapies Share Price & Price History

^$131.87

+0.30 (1.20%)

As of 04/2/2025 01:00 AM ET

Intra-Cellular Therapies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/4/2024	Sharon Mates	CEO	Sell	51,000	$85.80	$4,375,800.00	1,070,329
11/12/2024	Michael Halstead	President	Sell	22,869	$89.12	$2,038,085.28
8/30/2024	Sharon Mates	CEO	Sell	34,396	$72.84	$2,505,404.64	1,070,329
8/27/2024	Sharon Mates	CEO	Sell	40,513	$73.58	$2,980,946.54	1,070,329
8/23/2024	Sharon Mates	CEO	Sell	28,680	$74.46	$2,135,512.80	1,070,329
8/21/2024	Sharon Mates	CEO	Sell	53,013	$75.65	$4,010,433.45	1,070,329
8/16/2024	Mark Neumann	EVP	Sell	18,714	$75.08	$1,405,047.12	29,700
6/24/2024	Rory B. Riggs	Director	Sell	4,462	$75.57	$337,193.34	116,600
6/18/2024	Robert L. Van Nostrand	Director	Sell	20,000	$75.91	$1,518,200.00	9,690
3/11/2024	Lawrence J. Hineline	CFO	Sell	10,121	$65.96	$667,581.16
3/11/2024	Michael Halstead	EVP	Sell	7,345	$65.97	$484,549.65	19,803
3/11/2024	Sharon Mates	CEO	Sell	20,565	$65.21	$1,341,043.65	1,050,309
3/7/2024	Lawrence J. Hineline	CFO	Sell	13,132	$66.60	$874,591.20	29,700
3/7/2024	Sharon Mates	CEO	Sell	40,712	$66.50	$2,707,348.00	1,050,309
3/7/2024	Suresh K. Durgam	EVP	Sell	6,450	$66.56	$429,312.00	16,170
2/26/2024	Joel S. Marcus	Director	Sell	26,328	$68.68	$1,808,207.04	39,662
2/26/2024	Lawrence J. Hineline	CFO	Sell	13,337	$69.43	$925,987.91
2/26/2024	Michael Halstead	EVP	Sell	7,907	$69.53	$549,773.71	29,700
2/26/2024	Sharon Mates	CEO	Sell	22,590	$69.79	$1,576,556.10	1,050,309
1/18/2024	Sharon Mates	CEO	Sell	67,917	$65.19	$4,427,509.23	1,050,309
1/16/2024	Sharon Mates	CEO	Sell	75,361	$67.25	$5,068,027.25	1,050,309
1/11/2024	Michael Halstead	EVP	Sell	50,000	$66.83	$3,341,500.00
1/2/2024	Suresh K. Durgam	EVP	Sell	62,282	$70.60	$4,397,109.20
12/13/2023	Suresh K. Durgam	EVP	Sell	21,262	$65.00	$1,382,030.00
11/6/2023	Mark Neumann	EVP	Sell	42,393	$55.63	$2,358,322.59	29,700
9/18/2023	Sharon Mates	CEO	Sell	55,587	$53.76	$2,988,357.12	1,094,722
8/7/2023	Mark Neumann	EVP	Sell	55,300	$58.79	$3,251,087.00	45,339
7/17/2023	Suresh K. Durgam	EVP	Sell	1,842	$65.00	$119,730.00	21,262
6/14/2023	Lawrence J. Hineline	CFO	Sell	81,854	$63.97	$5,236,200.38
4/17/2023	Robert L. Van Nostrand	Director	Sell	10,000	$63.00	$630,000.00	9,345
3/28/2023	Mark Neumann	EVP	Sell	15,604	$54.31	$847,453.24	45,339
3/13/2023	Lawrence J. Hineline	CFO	Sell	5,582	$44.93	$250,799.26
3/13/2023	Sharon Mates	CEO	Sell	20,565	$44.99	$925,219.35	1,130,309
3/13/2023	Suresh K. Durgam	EVP	Sell	7,344	$45.04	$330,773.76	23,104
3/10/2023	Lawrence J. Hineline	CFO	Sell	15,663	$43.06	$674,448.78
3/10/2023	Mark Neumann	EVP	Sell	8,550	$43.34	$370,557.00	57,357
3/10/2023	Sharon Mates	CEO	Sell	41,770	$43.15	$1,802,375.50	1,130,309
3/1/2023	Mark Neumann	EVP	Sell	7,241	$50.01	$362,122.41	49,199
2/24/2023	Lawrence J. Hineline	CFO	Sell	7,455	$47.03	$350,608.65
2/24/2023	Mark Neumann	EVP	Sell	4,046	$47.12	$190,647.52	56,440
2/24/2023	Sharon Mates	CEO	Sell	22,590	$47.03	$1,062,407.70	1,100,309
2/24/2023	Suresh K. Durgam	SVP	Sell	7,906	$47.14	$372,688.84	23,104
2/21/2023	Lawrence J. Hineline	CFO	Sell	10,443	$46.82	$488,941.26
2/21/2023	Mark Neumann	EVP	Sell	3,898	$47.01	$183,244.98	52,580
2/21/2023	Sharon Mates	CEO	Sell	27,848	$46.83	$1,304,121.84	1,100,309
2/21/2023	Suresh K. Durgam	SVP	Sell	8,354	$46.84	$391,301.36	23,104
2/17/2023	Lawrence J. Hineline	CFO	Sell	53,968	$49.83	$2,689,225.44
12/19/2022	Joel S. Marcus	Director	Sell	5,000	$50.82	$254,100.00	29,233
12/13/2022	Sharon Mates	CEO	Sell	33,083	$55.00	$1,819,565.00	1,100,309

SEC Filings (Institutional Ownership Changes) for Intra-Cellular Therapies (NASDAQ:ITCI)

92.33% of Intra-Cellular Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Intra-Cellular Therapies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/4/2025	Osaic Holdings Inc.	797	$0.11M	0.0%	-21.7%	0.001%
6/18/2025	Voya Investment Management LLC	44,125	$5.82M	0.0%	-48.3%	0.041%
5/28/2025	Strs Ohio	7,355	$0.97M	0.0%	N/A	0.007%
5/21/2025	Geneos Wealth Management Inc.	244	$32K	0.0%	+121.8%	0.000%
5/21/2025	Bluefin Capital Management LLC	10,000	$1.32M	1.0%	N/A	0.009%
5/20/2025	Focus Partners Wealth	3,214	$0.42M	0.0%	-8.4%	0.003%
5/19/2025	SCS Capital Management LLC	72,743	$9.60M	0.1%	N/A	0.068%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	284,371	$37.51M	0.0%	-15.2%	0.267%
5/16/2025	Woodline Partners LP	123,750	$16.33M	0.1%	N/A	0.116%
5/16/2025	Arete Wealth Advisors LLC	12,117	$1.60M	0.1%	-50.0%	0.011%
5/16/2025	Caxton Associates LLP	214,783	$28.33M	1.0%	N/A	0.202%
5/16/2025	Goldman Sachs Group Inc.	1,473,764	$194.42M	0.0%	+291.5%	1.384%
5/16/2025	Dynamic Technology Lab Private Ltd	19,560	$2.58M	0.4%	N/A	0.018%
5/16/2025	Twin Securities Inc.	440,690	$58.14M	30.0%	N/A	0.414%
5/16/2025	PenderFund Capital Management Ltd.	1,900	$0.25M	0.0%	N/A	0.002%
5/16/2025	Pentwater Capital Management LP	5,190,000	$684.67M	5.7%	N/A	4.872%
5/16/2025	Murchinson Ltd.	120,049	$15.84M	0.9%	N/A	0.113%
5/16/2025	Polar Asset Management Partners Inc.	324,020	$42.75M	1.0%	N/A	0.304%
5/16/2025	HGC Investment Management Inc.	85,800	$11.32M	4.2%	N/A	0.081%
5/16/2025	Cinctive Capital Management LP	140,000	$18.47M	1.4%	N/A	0.131%
5/16/2025	Alliancebernstein L.P.	423,171	$55.83M	0.0%	-59.9%	0.397%
5/16/2025	Beryl Capital Management LLC	541,642	$71.45M	26.7%	N/A	0.508%
5/16/2025	AQR Arbitrage LLC	252,316	$33.29M	0.8%	N/A	0.237%
5/16/2025	AQR Capital Management LLC	266,327	$35.13M	0.0%	-50.4%	0.250%
5/16/2025	Amundi	561,266	$74.01M	0.0%	+20,466.7%	0.527%
5/16/2025	Adage Capital Partners GP L.L.C.	298,391	$39.36M	0.1%	-56.0%	0.280%
5/16/2025	ADAR1 Capital Management LLC	48,044	$6.34M	1.2%	N/A	0.045%
5/15/2025	Empyrean Capital Partners LP	228,000	$30.08M	1.1%	N/A	0.214%
5/15/2025	Paulson & CO. Inc.	21,500	$2.84M	0.2%	N/A	0.020%
5/15/2025	TIG Advisors LLC	1,057,892	$139.56M	8.7%	N/A	0.993%
5/15/2025	Cubist Systematic Strategies LLC	165,377	$21.82M	0.1%	+5.8%	0.155%
5/15/2025	Royal Bank of Canada	240,601	$31.74M	0.0%	+46.3%	0.226%
5/15/2025	Alpine Global Management LLC	50,000	$6.60M	1.7%	N/A	0.047%
5/15/2025	Vazirani Asset Management LLC	25,000	$3.30M	12.1%	N/A	0.023%
5/15/2025	Nomura Holdings Inc.	14,313	$1.89M	0.0%	N/A	0.013%
5/15/2025	Vident Advisory LLC	1,586	$0.21M	0.0%	N/A	0.001%
5/15/2025	Magnetar Financial LLC	435,715	$57.48M	0.8%	N/A	0.409%
5/15/2025	WPG Advisers LLC	380	$50K	0.0%	N/A	0.000%
5/15/2025	BNP Paribas Financial Markets	247,848	$32.70M	0.0%	+485.8%	0.233%
5/15/2025	Carlson Capital L.P.	23,000	$3.03M	1.2%	N/A	0.022%
5/15/2025	Eisler Capital Management Ltd.	40,092	$5.29M	0.0%	N/A	0.038%
5/14/2025	Ieq Capital LLC	36,845	$4.86M	0.0%	+13.7%	0.035%
5/14/2025	GABELLI & Co INVESTMENT ADVISERS INC.	202,300	$26.69M	4.1%	N/A	0.190%
5/14/2025	Gamco Investors INC. ET AL	38,100	$5.03M	0.1%	N/A	0.036%
5/14/2025	Gabelli Funds LLC	325,700	$42.97M	0.3%	N/A	0.306%
5/14/2025	Rafferty Asset Management LLC	2,484	$0.33M	0.0%	-41.3%	0.002%
5/14/2025	FORA Capital LLC	26,176	$3.45M	0.4%	N/A	0.025%
5/14/2025	Westchester Capital Management LLC	460,267	$60.72M	3.2%	N/A	0.432%
5/14/2025	Comerica Bank	2,019	$0.27M	0.0%	-99.0%	0.002%
5/14/2025	PSquared Asset Management AG	229,086	$30.22M	22.6%	N/A	0.215%
5/14/2025	SVB Wealth LLC	359	$47K	0.0%	N/A	0.000%
5/14/2025	Groupe la Francaise	88,438	$11.67M	0.2%	N/A	0.083%
5/14/2025	AlphaQuest LLC	2,421	$0.32M	0.0%	-39.2%	0.002%
5/14/2025	Van Hulzen Asset Management LLC	4,600	$0.61M	0.1%	-8.0%	0.004%
5/14/2025	Compound Planning Inc.	2,216	$0.29M	0.0%	N/A	0.002%
5/14/2025	Carmignac Gestion	38,819	$5.12M	0.1%	N/A	0.036%
5/14/2025	Hsbc Holdings PLC	253,660	$33.46M	0.0%	N/A	0.238%
5/14/2025	Quantbot Technologies LP	13,020	$1.72M	0.1%	N/A	0.012%
5/14/2025	Wellington Management Group LLP	190,370	$25.11M	0.0%	-81.6%	0.179%
5/13/2025	Northern Trust Corp	634,535	$83.71M	0.0%	+4.1%	0.596%
5/13/2025	Versor Investments LP	56,656	$7.47M	1.2%	N/A	0.053%
5/13/2025	Algert Global LLC	59,701	$7.88M	0.2%	+140.1%	0.056%
5/13/2025	State of New Jersey Common Pension Fund D	33,199	$4.38M	0.0%	-9.8%	0.031%
5/13/2025	American Century Companies Inc.	10,773	$1.42M	0.0%	-96.6%	0.010%
5/13/2025	Sei Investments Co.	191,628	$25.28M	0.2%	-3.1%	0.180%
5/13/2025	Kovitz Investment Group Partners LLC	2,202	$0.29M	0.0%	N/A	0.002%
5/13/2025	Russell Investments Group Ltd.	8,336	$1.10M	0.0%	-74.2%	0.008%
5/13/2025	HighTower Advisors LLC	3,858	$0.51M	0.0%	-7.7%	0.004%
5/12/2025	Longfellow Investment Management Co. LLC	574	$76K	0.0%	N/A	0.001%
5/12/2025	Nuveen LLC	304,125	$40.12M	0.0%	N/A	0.286%
5/12/2025	Invesco Ltd.	85,066	$11.22M	0.0%	-97.2%	0.080%
5/12/2025	Covestor Ltd	1,233	$0.16M	0.1%	-41.3%	0.001%
5/12/2025	Wolverine Asset Management LLC	40,265	$5.31M	0.1%	N/A	0.038%
5/12/2025	National Bank of Canada FI	133,000	$17.55M	0.0%	N/A	0.125%
5/12/2025	Swiss National Bank	185,200	$24.43M	0.0%	-1.0%	0.174%
5/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	268	$35K	0.0%	+152.8%	0.000%
5/12/2025	Maryland State Retirement & Pension System	4,810	$0.64M	0.0%	-18.2%	0.005%
5/9/2025	Headlands Technologies LLC	6,637	$0.88M	0.1%	-65.2%	0.006%
5/9/2025	Deutsche Bank AG	693,427	$91.48M	0.0%	-10.6%	0.651%
5/9/2025	Chicago Capital Management LLC	90,200	$11.90M	7.4%	N/A	0.085%
5/9/2025	Charles Schwab Investment Management Inc.	895,664	$118.16M	0.0%	-1.2%	0.841%
5/9/2025	Vanguard Group Inc.	9,519,968	$1.26B	0.0%	-2.1%	8.937%
5/9/2025	West Michigan Advisors LLC	1,552	$0.21M	0.1%	N/A	0.001%
5/9/2025	ABC Arbitrage SA	40,679	$5.37M	1.0%	N/A	0.038%
5/9/2025	Cary Street Partners Financial LLC	1,500	$0.20M	0.0%	N/A	0.001%
5/9/2025	Sfmg LLC	1,748	$0.23M	0.0%	N/A	0.002%
5/9/2025	ING Groep NV	376,800	$49.71M	0.3%	+2,914.4%	0.354%
5/9/2025	Earned Wealth Advisors LLC	1,664	$0.22M	0.0%	N/A	0.002%
5/9/2025	DCF Advisers LLC	3,500	$0.46M	0.2%	-96.5%	0.003%
5/9/2025	J. Safra Sarasin Holding AG	8,799	$1.16M	0.0%	-71.2%	0.008%
5/9/2025	Bank of Nova Scotia	11,400	$1.50M	0.0%	N/A	0.011%
5/9/2025	PNC Financial Services Group Inc.	2,516	$0.33M	0.0%	-68.7%	0.002%
5/8/2025	Commerce Bank	2,431	$0.32M	0.0%	-65.7%	0.002%
5/8/2025	Jefferies Financial Group Inc.	29,909	$3.95M	0.0%	N/A	0.028%
5/8/2025	Alberta Investment Management Corp	79,000	$10.42M	0.1%	+1,449.0%	0.074%
5/8/2025	US Bancorp DE	2,195	$0.29M	0.0%	-39.4%	0.002%
5/8/2025	Alpine Associates Management Inc.	719,500	$94.92M	5.0%	N/A	0.675%
5/8/2025	Vestcor Inc	128,319	$16.93M	0.6%	N/A	0.120%
5/8/2025	XTX Topco Ltd	2,085	$0.28M	0.0%	N/A	0.002%
5/8/2025	GSA Capital Partners LLP	7,376	$0.97M	0.1%	N/A	0.007%

Data available starting January 2016

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Today's Range

Now: $131.87

$131.87

50 Day Range

MA: $131.87

$131.87

52 Week Range

Now: $131.87

$70.90

$131.98

Volume

N/A

Average Volume

1,573,750 shs

Market Capitalization

$14.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Intra-Cellular Therapies?: Intra-Cellular Therapies' top insider shareholders include:
Sharon Mates (CEO)
Rory B Riggs (Director)
Joel S Marcus (Director)
Lawrence J Hineline (CFO)
Mark Neumann (EVP)
Michael Halstead (EVP)
Suresh K Durgam (EVP)
Nostrand Robert L Van (Director)
Michael Halstead (President)
Suresh K Durgam (EVP)
Learn More about top insider investors at Intra-Cellular Therapies.